thirty-seven patients with acute myeloid leukemia in relapse or at initial diagnosis but resistant to conventional induction regimen have been treated by single-cycle timed sequential chemotherapy , including continuous infusion of cytarabine over 72 hours on days 1-3 and 8-10 and short injections of daunorubicin on days 1-3 .
C0023467
acute myeloid leukemia
C0011015
daunorubicin